Scribe Therapeutics, Inc. (SCTX)
28.05
-4.95
(-15.00%)
USD |
NASDAQ |
Sep 21, 16:00
28.61
+0.56
(+2.00%)
After-Hours: 20:00
Scribe Therapeutics Total Assets (Quarterly) : 57.93M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.93M |
| Date | Value |
|---|---|
| March 31, 2026 | 65.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.995B |
| Cypherpunk Technologies, Inc. | 142.97M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 102.42M |
| Shareholders Equity (Quarterly) | -44.49M |
| Debt to Equity Ratio | -0.9726 |
| Current Ratio | 0.5731 |